Detalhe da pesquisa
1.
Macrocytic anemias.
Curr Opin Hematol
; 31(3): 82-88, 2024 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334746
2.
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
N Engl J Med
; 384(17): 1601-1612, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913638
3.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
N Engl J Med
; 384(17): 1589-1600, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913637
4.
Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD.
Kidney Int
; 104(1): 25-28, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349056
5.
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
Nephrol Dial Transplant
; 38(10): 2358-2367, 2023 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096396
6.
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.
Am J Hematol
; 97(9): 1178-1188, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751858
7.
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics.
Am Heart J
; 235: 1-11, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129989
8.
Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials.
Nephrol Dial Transplant
; 36(11): 2039-2048, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188693
9.
The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysisâ©.
Clin Nephrol
; 87 (2017)(3): 124-133, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128726
10.
Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Am J Hematol
; 91(4): 371-8, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26749142
11.
Stress reticulocytes lose transferrin receptors by an extrinsic process involving spleen and macrophages.
Am J Hematol
; 91(9): 875-82, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27194638
12.
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.
J Am Soc Nephrol
; 26(10): 2578-87, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736045
13.
Ferric citrate controls phosphorus and delivers iron in patients on dialysis.
J Am Soc Nephrol
; 26(2): 493-503, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25060056
14.
Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
Am J Kidney Dis
; 61(5): 759-66, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23369827
15.
Self-renewal in late-stage erythropoiesis.
Blood
; 117(9): 2562-4, 2011 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21372160
16.
EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis.
Nat Commun
; 12(1): 7334, 2021 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921133
17.
Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation.
Chromosome Res
; 17(1): 47-64, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19172406
18.
A multiscale model to design therapeutic strategies that overcome drug resistance to tyrosine kinase inhibitors in multiple myeloma.
Math Biosci
; 319: 108293, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809782
19.
Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
Biochem Biophys Res Commun
; 390(2): 295-301, 2009 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19799863
20.
Sickle cell disease today: a 75-year journey from "first molecular disease" to "first gene-editing therapy".
Swiss Med Wkly
; 154: 3829, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616700